When comparing the frequency of patients with elevated levels of IL-10, IL-6, and TNF-α and their combinations or overlaps, we found a significant difference (p < 0.001) between the non-, moderate, severe, and critical COVID-19 groups (Figure 2A–D). This evidence concerns the gene IL6 and COVID-19.